Clinical Trials Directory

Trials / Unknown

UnknownNCT00989547

Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM)

Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children With Type 1 Diabetes - A Pilot Study.

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers

Summary

Type 1 diabetes (T1D) is still associated with tremendous morbidity and premature mortality. Patients require multiple daily insulin injections throughout their lives as well as close monitoring of their diet and blood sugar levels to prevent complications. Unfortunately, there is presently no permanent cure for diabetes. Whole pancreas or islet cell transplantation is available only to a very limited number of patients and necessitates potential lifelong immunosuppressive therapy. Autologous stem cell transplants have been used successfully for ALL (acute lymphoblastic leukemia), AML (acute myeloblastic leukemia) and for the treatment of a variety of cancers including breast cancer and neuroblastomas, and more recently for the treatment of autoimmune disorders such as multiple sclerosis (MS), lupus-like disease, and rheumatic disorders. Recently it was shown that bone marrow-derived stems cells transplanted into diabetic mice led to reduced hyperglycemia within 7 days after transplantation and was sustained until they were sacrificed at 35 days post-transplantation. The investigators' goal is to transfuse autologous umbilical cord blood into 23 children (Germany 10 and 20 Controls) with T1D in an attempt to regenerate pancreatic islet insulin producing beta cells and improve blood glucose control. As secondary goals, the investigators aim to track the migration of transfused cord blood stem and study the potential changes in metabolism/immune function leading to islet regeneration.

Conditions

Interventions

TypeNameDescription
OTHERUmbilical Cord Blood VITA 34Intervention type: Autologous Umbilical Cord Blood Transfusion

Timeline

Start date
2008-09-01
Primary completion
2014-09-01
First posted
2009-10-05
Last updated
2013-07-23

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00989547. Inclusion in this directory is not an endorsement.

Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM) (NCT00989547) · Clinical Trials Directory